altimmune
The Senior Director, Drug Substance Development provides strategic and technical leadership for drug substance development and manufacturing within the CMC organization. This role leads phase-appropriate development, scale-up, technology transfer, and manufacturing for peptide drug substance programs while serving as a key technical interface with external CDMOs and internal teams. The position is based in Morristown, NJ, with hybrid work flexibility.
Headquarters
Gaithersburg, Maryland, United States
Company Size
11-50 employees
Founded
1997
Sucuri is a website security and performance platform that protects websites through a cloud-based Web Application Firewall (WAF) and Content Delivery Network (CDN). It shields sites from hacks, malware, and DDoS attacks while accelerating delivery and improving reliability. The service also provides malware removal, continuous security monitoring, and incident response to help maintain uptime and trust. Traffic is routed through Sucuri’s global network via DNS changes and lightweight scripts to enforce security controls across environments.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for altimmune.
altimmune didn’t post a salary, so this is our estimate from similar listings.
Director, Drug Substance Commercial Manufacturing
kaileratherapeutics
Director, Small Molecule Drug Substance Development
Cogent Biosciences
Associate Director, Drug Substance (Process Chemistry)
Pulmovant
Vice President, Drug Substance
BioCryst Pharmaceuticals
Senior Drug Substance Scientist
Zealand Pharma
Senior Drug Substance Scientist
Zealand Pharma